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Abstract. Magnetic nanoparticles and microparticles can be found in biological tissues for a 
variety of reasons including pathological deposition of biogenic particles, administration of 
synthetic particles for scientific or clinical reasons, and the inclusion of biogenic magnetic 
particles for the sensing of the geomagnetic field. In applied magnetic fields, the magnetisation 
of tissue protons can be manipulated with radiofrequency radiation such that the macroscopic 
magnetisation of the protons precesses freely in the plane perpendicular to the applied static 
field. The presence of magnetic particles within tissue enhances the rate of dephasing of proton 
precession with higher concentrations of particles resulting in higher dephasing rates. Magnetic 
resonance imaging instruments can be used to measure and image the rate of decay of spin 
echo recoverable proton transverse magnetisation (R2) within tissues enabling the measurement 
and imaging of magnetic particle concentrations with the aid of suitable calibration curves. 
Applications include the non-invasive measurement of liver iron concentrations in iron-
overload disorders and measurement and imaging of magnetic particle concentrations used in 
magnetic hyperthermia therapy.  Future applications may include the tracking of magnetically 
labelled drugs or biomolecules and the measurement of fibrotic liver damage. 
1. Introduction 
Magnetic iron oxide nanoparticles can occur naturally in biological tissue or can be introduced for 
scientific or clinical reasons [1].  Although their concentrations and spatial distribution can be deduced 
in experiments on excised tissue or sacrificed animals, there are many circumstances in which it is 
desirable to measure and image their concentrations in vivo.  Magnetic resonance imaging (MRI) is 
based on the resonance of nuclei (typically protons, which are plentiful in biological tissues) with 
radiofrequency radiation in the presence of a static magnetic field [2].  Since the rate of precession of 
tissue protons is proportional to the local magnetic field strength, local fluctuations in field strength 
induced by the presence of magnetic nanoparticles can enhance the rate at which the transverse 
magnetisation of tissue protons decays with time [3, 4].  In many situations, magnetic nanoparticle 
concentrations in tissues are sufficiently high to be the main determinant of the tissue proton 
transverse relaxation rate (R2), with higher concentrations resulting in higher values of tissue R2.  The 
recent development of techniques for measuring and imaging R2 in various biological tissues using 
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clinical magnetic resonance imagers makes such techniques readily available thus enabling 
measurement and imaging of magnetic nanoparticle concentrations once suitable calibration curves 
have been determined. 
 
2. Pathological iron oxide nanoparticles 
Iron overload disorders such as thalassaemia and hereditary haemochromatosis affect up to 0.5% of 
the world’s population.  These disorders result in the accumulation of iron in the form of nanoparticles 
of iron(III) oxyhydroxide in organs of the body such as the liver, heart, spleen, and pancreas.  
Knowledge of the concentrations of these particles is often essential for appropriate management of 
iron overload conditions.  The currently accepted and widely used method of measurement is chemical 
analysis of needle biopsy specimens of the liver.  However, needle biopsy is an invasive procedure 
that carries a degree of risk and has associated sampling errors owing to the uneven distribution of iron 
within tissues. 
We have developed a method of measuring and imaging R2 within the liver [5].  An example R2 
image of the liver is shown in figure 1.  R2 is highly dependent on tissue iron concentration owing to 
spin-spin interactions between protons of water molecules and the iron oxyhydroxide nanoparticles 
within the tissue.  The high degree of correlation between R2 and tissue iron concentration has enabled 
the development of a method for non-invasively measuring and imaging liver iron concentrations 
(figure 2) [6].  The method has a demonstrated dynamic range of measurement of liver iron 
concentration from 0.3 to 42.7 mg Fe/g dry liver tissue.  The large dynamic range and sensitivity and 
specificity of liver R2 to needle biopsy measurements together with a demonstrated high degree of 
reproducibility on multiple magnetic resonance imaging units offers readily available non-invasive 




Figure 1.  R2 image of iron-loaded human 
liver.  High R2 corresponds to high iron 
concentration. The R2 image of the liver is 
superimposed over a standard T2-weighted 
image. Note that T2 is the proton transverse 
relaxation time (T2 = 1/R2). 
 Figure 2.  Correlation between liver iron 
concentration (LIC) measured in vivo 
using proton transverse relaxometry and 
LIC measured by needle biopsy in 105 
human subjects (adapted from [6]). 
 
Furthermore, there is promise that the ability to image liver iron concentrations may enable the 
detection of distorted liver architecture such as fibrosis and cirrhosis by virtue of the fact that these 
distortions result in altered patterns of iron oxyhydroxide nanoparticle deposition within the tissue 
(figure 3).  Fibrosis and cirrhosis involve the proliferation of scar tissue within the liver.  The scar 
tissue tends not to incorporate iron at the same concentrations as the liver cells and hence the presence 



















Figure 3.  R2 images of liver with corresponding R2 distributions for two 
chronic hepatitis C patients.  (a) patient with zero fibrosis score; (b) 
patient with cirrhosis (high fibrosis score).  Note the distortion of the R2 
distribution away from normal for the patient with cirrhosis. 
 
3. Magnetic particles for hyperthermia therapy 
Mapping of tissue R2 can also be used to image concentrations of magnetic particles introduced into 
the body such as those used for magnetic hyperthermia therapy [8, 9].  Magnetic hyperthermia therapy 
involves the application of alternating magnetic fields to tissues containing magnetic particles that 
have been targeted to tumour tissue in order to generate heat in the particles.  Raised tissue 
temperatures can help to kill cancer cells and have been shown to increase the effectiveness of radio- 
and chemo-therapy. A safety concern of the technique is ensuring that the concentration of 
ferrimagnetic material in healthy parts of the liver is low enough to avoid unwanted heating of healthy 
liver tissue.  Hence imaging of magnetic particle distributions in vivo may play a role in assessing the 
effectiveness of magnetic particle targeting of tumours before application of the ac magnetic field to 





Figure 4. In vivo R2-image of rabbit liver 
embolized with ferrimagnetic iron particles 
(taken from [8]).  
 Figure 5. Graph of mean R2 against iron 
concentration for approximate 1 cm cubes of 
tissue dissected from livers of rabbits loaded 
with ferrimagnetic particles (taken from [8]). 
Vertical bars through each data point indicate 
the width of the Gaussian distribution of R2 
observed for each sample of liver. 
 
Figure 4 shows an R2 image of a rabbit liver embolized with ferrimagnetic particles obtained in 
vivo.  Figure 5 shows the calibration curve relating liver R2 to concentration of the ferrimagnetic 
particles obtained by dissecting the excised liver into approximately 1 cm sized cubes post mortem 
and both chemically assaying for iron and measuring R2 for each cube.  Studies of heating rates and 
ferrimagnetic particle concentrations may lead to the R2 images being used to predict local heating 
rates within the liver. 
 
4. Ferrimagnetic particle detection limits 
Since there are many situations where the concentrations of ferrimagnetic particles may be somewhat 
lower than those encountered in, for example, magnetic hyperthermia therapy, the limit of detection of 
ferrimagnetic particles by clinical magnetic resonance imaging systems has been investigated [10].  
Such situations may include the use of nanoparticle “labels” within the human body.  Magnetic 
nanoparticles functionalised with antigens for biomolecules of interest could be introduced into the 
body in order to magnetically label the biomolecules.  Measurements on agar gels loaded with 
different concentrations of ferrimagnetic iron oxide nanoparticles indicate that ferrimagnetic iron 
concentrations as low as 50 µg/ml can be measured and imaged [10].  Although this detection limit is 
not sufficiently low to enable measurement and imaging of the reported biogenic magnetite particle 
concentrations in the human brain [11, 12], the use of MRI microscopy systems with much higher 
field gradients than those available with clinical systems may aid in the study of these particles in 
excised human brain samples.  MRI microscopy might also play a role in elucidating the distribution 
of magnetic particles in the geomagnetic sensory organs of animals capable of magnetic navigation. 
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